<unk><unk>  (PNC) literally means inflammation of the cranial nerves. It is a rare neurological disorder characterized by multiple cranial nerve palsies sparing the spinal cord. The disease is a Guillain-Barré syndrome-Miller Fisher syndrome interface. SARS-CoV-2 virus which causes COVID-19 is emerging as a neurotropic virus. The pathogenesis of<unk> <unk>  is characterized by the demyelination of lower cranial nerves. COVID-19-associated PNC must be differentiated from other diseases that cause bulbar weakness, facial weakness, and ophthalmoparesis. The diagnosis of PNC is clinical and confirmed by Nerve Conduction Studies (NCS). There is only one case of COVID-19<unk>  PNC reported so far (first six months of the COVID-19 pandemic). Fixation nystagmus, bilateral abducens palsy, impaired visual acuity, gaze palsy and loss of deep tendon reflexes has been observed with no gait pathology. Treatment with acetaminophen caused complete recovery within 2 weeks. As the disease is believed to be an immune response to COVID-19 infection, the prevention of COVID-19 itself is the most promising primary prevention strategy.
COVID-19-associated polyneuritis cranialis
COVID-19-associated meningitis
COVID-19-associated stroke
COVID-19-associated encephalitis
COVID-19-associated headache
COVID-19-associated cytokine storm
COVID-19-associated hemodialysis
COVID-19-associated Guillain-Barre syndrome